Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Incyte Bolsters Dermatology Ambitions With Vitiligo Approval For Topical Ruxolitinib
Jul 19 2022
•
By
Joseph Haas
Opzelura is the first approved drug therapy for vitiligo • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip